Syphilis Treatment Drugs Market Analysis

  • Report ID: 3072
  • Published Date: Sep 25, 2024
  • Report Format: PDF, PPT

Syphilis Treatment Drugs Market Analysis

The market is segmented by disease type into primary, secondary, tertiary syphilis, and others, out of which, the primary and secondary syphilis segments are anticipated to hold the largest share in the syphilis treatment drugs market on account of the commonness of the disease in its earlier and transmissible stages. Additionally, majority of the cases of primary and secondary syphilis occur among homosexual men. Another report by the CDC states, in 2019, of the total syphilis cases, 38,992 were of primary and secondary (P&S) syphilis. Out of these, 56% of the total incidents accounted for all male cases. Rising openness towards same-sex is also estimated to offer opportunities to the growth of this market segment in the near future. Moreover, based on distribution channel, the segment for hospital pharmacies is evaluated to occupy the largest market share during the forecast period, which can be credited to the ease to receive prescribed medicines from the hospital facility itself. 

Our in-depth analysis of the global market includes the following segments

By Disease Type

  • Primary Syphilis
  • Secondary Syphilis
  • Tertiary Syphilis
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3072
  • Published Date: Sep 25, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing incidences of unprotected sex worldwide and growing occurrence of syphilis in developing nations are major growth drivers for the market.

The market is anticipated to attain a notable CAGR over the forecast period, i.e., 2021 – 2029.

Lack of trained laboratory personnel in under developed nations is estimated to hamper the market growth.

Middle East & Africa region will provide more business growth opportunities on the back of high prevalence of syphilis in Africa.

The major players in the market are GlaxoSmithKline plc, Johnson & Johnson Services, Inc., F. Hoffman-La Roche Ltd, Abbott Laboratories, PerkinElmer, Inc., and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample